Single center experience and literature review of kidney transplantation from non‐ideal donors with acute kidney injury: Risk and reward

Author:

Webb Christopher J.1,McCracken Emily1,Jay Colleen L.1ORCID,Sharda Berjesh1ORCID,Garner Matthew1,Farney Alan C.1,Orlando Giuseppe1ORCID,Reeves‐Daniel Amber2,Mena‐Gutierrez Alejandra2,Sakhovskaya Natalia2,Stratta Bobby1,Stratta Robert J.1ORCID

Affiliation:

1. Department of Surgery Section of Transplantation and the Section of Nephrology Winston‐Salem North Carolina USA

2. Department of Medicine, Section of Nephrology Wake Forest School of Medicine Winston‐Salem North Carolina USA

Abstract

AbstractIntroductionThere is limited experience transplanting kidneys from either expanded criteria donors (ECD) or donation after circulatory death (DCD) deceased donors with terminal acute kidney injury (AKI).MethodsAKI kidneys were defined by a donor terminal serum creatinine level >2.0 mg/dL whereas non‐ideal deceased donor (NIDD) kidneys were defined as AKI/DCD or AKI/ECDs.ResultsFrom February 2007 to March 2023, we transplanted 266 single AKI donor kidneys including 29 from ECDs, 29 from DCDs (n = 58 NIDDs), and 208 from brain‐dead standard criteria donors (SCDs). Mean donor age (43.7 NIDD vs. 33.5 years SCD), KDPI (66% NIDD vs. 45% SCD), and recipient age (57 NIDD vs. 51 years SCD) were higher in the NIDD group (all p < .01). Mean waiting times (17.8 NIDD vs. 24.2 months SCD) and dialysis duration (34 NIDD vs. 47 months SCD) were shorter in the NIDD group (p < .05). Delayed graft function (DGF, 48%) and 1‐year graft survival (92.7% NIDD vs. 95.9% SCD) was similar in both groups. Five‐year patient and kidney graft survival rates were 82.1% versus 89.9% and 82.1% versus 75.2% (both p = NS) in the NIDD versus SCD groups, respectively.ConclusionsThe use of kidneys from AKI donors can be safely liberalized to include selected ECD and DCD donors.

Publisher

Wiley

Subject

Transplantation

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3